Hotgen Biotech Co., Ltd was founded in 2005 and is located in the Biomedical Base of Zhongguancun High-Tech Park in Beijing. It is a national-level high-tech company dedicated to developing and manufacturing innovative in-vitro diagnostic (IVD), point-of-care testing (POCT), and biodefense products.
Now, Hotgen has four technology platforms:
1. Chemiluminescence Immunoassay CLIA System. ( MQ60 and MQ plus)
Test parameters:
1) Cardiac: hs-cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2
2) Inflammation Monitoring: CRP, PCT, IL-6
3) Kidney Function: NGAL, Cys-C
4) Tumor Marker: AFP, GP73, AFP-L3, DCP
5) Bone Metabolism: 25-OH-Vitamin D
2. Up-converting Phospher Immunoassay Test System. ( UPT-3A)
Test parameters:
1) Cardiac: cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2
2) Inflammation Monitoring: CRP, PCT, IL-6
3) Kidney Function: NGAL
4) Liver Function: AFP, GP73
5) Premature Birth: fFN
6) Rheumatoid Arthritis: anti-CCP
3. Colloidal Gold Semi-quantitative Rapid Test
PCT, anti-CCP, NT-proBNP, H-FABP, fFN, TP-Ab/IgM, NS1, IgM/IgG, combo NS1+IgM/IgG, Typhoid fever, Malaria Pf/Pv
4. Enzyme-Linked Immunosorbent Assay (ELISA) Test System
Anti-CCP, AMH, DCP, CA125, AFP, CEA, PSA, Lp-PLA2, GP73, HBV-LP, HE4
